Home β€Ί Healthcare β€Ί Medical Devices β€Ί Specimen Collection Cards Market

Specimen Collection Cards Market - Strategic Insights and Forecasts (2026-2031)

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Table of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. SPECIMEN COLLECTION CARDS MARKET BY SPECIMEN TYPE

5.1. Introduction

5.2. Blood

5.3. Saliva

5.4. Urine

5.5. Buccal Cells

5.6. Others

6. SPECIMEN COLLECTION CARDS MARKET BY MATERIAL

6.1. Introduction

6.2. Cellulose-Based

6.3. Fiber-Based

6.4. Others

7. SPECIMEN COLLECTION CARDS MARKET BY APPLICATION

7.1. Introduction

7.2. Newborn Screening (NBS)

7.3. Infectious Disease Testing

7.4. Therapeutic Drug Monitoring

7.5. Biomarker Monitoring

7.6. Others

8. SPECIMEN COLLECTION CARDS MARKET BY END-USER

8.1. Introduction

8.2. Hospitals & Clinics

8.3. Diagnostic Centers

8.4. Others

9. SPECIMEN COLLECTION CARDS MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. USA

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. Germany

9.4.2. France

9.4.3. United Kingdom

9.4.4. Spain

9.4.5. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. India

9.6.3. Japan

9.6.4. South Korea

9.6.5. Indonesia

9.6.6. Thailand

9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. QIAGEN

11.2. Revvity, Inc.

11.3. Eastern Business Forms, Inc.

11.4. Ahlstrom

11.5. ARCHIMED Life Science GmbH

11.6. GenTegra LLC

11.7. FortiusBio

11.8. CENTOGENE GmbH

11.9. F. Hoffmann-La Roche Ltd

11.10. Thermo Fisher Scientific Inc.

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

REPORT DETAILS

Report ID:KSI061615819
Published:Jan 2026
Pages:140
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us